Sun Pharmaceutical Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 7,317.74 | 6,260.20 | 5,214.01 |
| Operating Expense | 4,196.28 | 4,488.34 | 3,789.09 |
| Net Profit | 2,000.46 | 1,181.05 | 863.29 |
| Net Profit Margin | 27.34 | 18.87 | 16.56 |
| Earning Per Share | 8.30 | 4.90 | 3.60 |
| EBIDTA | 3,121.46 | 1,771.86 | 1,424.92 |
| Effective Tax Rate | 19.59 | 4.73 | 2.27 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 7317.74 |
| Operating Expense | 4196.28 |
| Net Profit | 2000.46 |
| Net Profit Margin | 27.34 |
| Earning Per Share | 8.30 |
| EBIDTA | 3121.46 |
| Effective Tax Rate | 19.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 23,003.33 | 20,275.17 | 20,812.14 |
| Operating Expenses Annual | 16,465.25 | 14,775.28 | 14,389.54 |
| Operating Profit Annual | 7,162.05 | 5,834.35 | 3,814.10 |
| Interest Annual | 893.21 | 784.08 | 472.18 |
| Depreciation | 1,238.27 | 1,600.62 | 1,600.87 |
| Net Profit Annual | 4,282.62 | 2,858.18 | 1,690.72 |
| Tax Annual | 747.95 | 591.47 | 50.33 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 23,003.33 |
| Operating Expenses Annual | 16,465.25 |
| Operating Profit Annual | 7,162.05 |
| Interest Annual | 893.21 |
| Depreciation | 1,238.27 |
| Net Profit Annual | 4,282.62 |
| Tax Annual | 747.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 326.46 | 410.28 | 419.53 |
| Cash Flow from Operations | 4,198.77 | -292.42 | 507.08 |
| Cash Flow from Investing | -202.03 | -265.35 | -685.64 |
| Cash Flow from Financing | -3,831.18 | 473.95 | 169.31 |
| Cash Flow at the End | 492.02 | 326.46 | 410.28 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 326.46 |
| Cash Flow from Operations | 4,198.77 |
| Cash Flow from Investing | -202.03 |
| Cash Flow from Financing | -3,831.18 |
| Cash Flow at the End | 492.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 31.13 | 28.78 | 32.43 |
| PBIT Margin (%) | 25.75 | 20.88 | 24.73 |
| PBT Margin (%) | 25.72 | 20.85 | 24.68 |
| Net PROFIT Margin (%) | 18.62 | 14.10 | 8.12 |
| Return On Networth / Equity (%) | 17.83 | 12.05 | 13.89 |
| Return On Networth /Employed (%) | 16.29 | 12.22 | 16.26 |
| Return On Assets (%) | 11.73 | 8.32 | 5.36 |
| Total Debt / Equity (X) | 0.47 | 0.40 | 0.27 |
| Asset Turnover Ratio (%) | 0.63 | 0.59 | 0.66 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 31.13 |
| PBIT Margin (%) | 25.75 |
| PBT Margin (%) | 25.72 |
| Net PROFIT Margin (%) | 18.62 |
| Return On Networth / Equity (%) | 17.83 |
| Return On Networth /Employed (%) | 16.29 |
| Return On Assets (%) | 11.73 |
| Total Debt / Equity (X) | 0.47 |
| Asset Turnover Ratio (%) | 0.63 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 7,364.36 | 8,114.61 | 9,235.71 |
| Total Current Assets Annual | 18,721.98 | 14,912.54 | 16,443.75 |
| Non Current Assets Annual | 24,521.06 | 26,110.38 | 24,522.34 |
| Total Shareholders Funds Annual | 24,339.85 | 23,694.40 | 23,748.36 |
| Total Assets Annual | 43,273.45 | 41,064.79 | 40,987.49 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 7,364.36 |
| Total Current Assets Annual | 18,721.98 |
| Non Current Assets Annual | 24,521.06 |
| Total Shareholders Funds Annual | 24,339.85 |
| Total Assets Annual | 43,273.45 |
EPS (INR)
Expected
8.96
Reported
9.00
Surprise
0.45%
Dec 2024
EPS beaten by 0.45%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.24%
